PBGD binding protein EMSA Kit
- Known as:
- PBGD binding protein EMSA Kit
- Catalog number:
- AY1379
- Product Quantity:
- 25 rxn
- Category:
- -
- Supplier:
- Panomics
- Gene target:
- PBGD binding protein EMSA Kit
Related genes to: PBGD binding protein EMSA Kit
- Gene:
- HMBS NIH gene
- Name:
- hydroxymethylbilane synthase
- Previous symbol:
- PBGD, UPS, PORC
- Synonyms:
- -
- Chromosome:
- 11q23.3
- Locus Type:
- gene with protein product
- Date approved:
- 1986-01-01
- Date modifiied:
- 2019-04-23
Related products to: PBGD binding protein EMSA Kit
Related articles to: PBGD binding protein EMSA Kit
- Iran established its first human milk bank (HMB) in 2016 to address high rates of neonatal mortality and prematurity-related complications. A national network of 19 HMBs was developed using a sustainable model that integrated local technological innovation and religious consensus. By partnering with domestic knowledge-based companies to manufacture automated pasteurizers, the program successfully bypassed international trade sanctions that made imported equipment cost-prohibitive. Furthermore, the program secured official Fatwas from high-ranking Shia authorities and a formal letter of consent from the Urmia Sunni Clergy Council to resolve "milk kinship" concerns across diverse religious regions. By 2024, the network reached an annual collection volume of over 6,785 liters, serving thousands of infants. This sustainable model provides a practical blueprint for other resource-limited and Muslim-majority countries to enhance neonatal outcomes by ensuring equitable access to donor human milk through national coordination and cultural integration. - Source: PubMed
Publication date: 2026/08/29
Hosseini MohammadbagherHosseini SobhanShafi Khalid Iqbal MohammadHeidarzadeh MohammadHabibelahi Abbas - Therapeutic drug monitoring (TDM) and pharmacokinetic studies of beta-lactam antibiotics in critically ill patients aim to define optimal dosing and require accurate measurement of unbound drug concentrations. This study compared the performance of two ultrafiltration devices, Centrifree and Amicon, for measuring unbound concentrations of cefepime, meropenem, flucloxacillin, piperacillin and tazobactam. - Source: PubMed
Publication date: 2026/08/29
Gregoire MatthieuWallis Steven CWilliams Paul GWon HayoungHernández-Mitre María PatriciaAbdul-Aziz Mohd HRoberts Jason A - Gestational diabetes mellitus (GDM) is defined as glucose intolerance first recognized during pregnancy. Offspring of GDM mothers have an increased risk of developing type 2 diabetes (T2D), obesity, and other metabolic disorders later in life. - Source: PubMed
Publication date: 2026/08/21
Hatem GadAndersson JonasHjort LineMinja Daniel T RCatellani FrancescaMøller Sofie LykkeAsplund OlofChristensen Dirk LundNielsen Birgitte BruunTheander Thor GArtner IsabellaShaat NaelLusingu John P AVaag AllanBygbjerg Ib ChristianSchmiegelow ChristentzeGrunnet Louise GrothPrasad Rashmi B - In 2023, international consensus recommendations suggested the use of prolonged-infusion beta-lactam antibiotics over short-infusion dosing in severely ill adult patients to improve mortality or clinical cure, although the certainty of evidence was very low. With the availability of several new randomized controlled trials (RCTs), this focused update re-evaluates the efficacy of prolonged versus short infusion among severely ill adult patients. The original Population, Intervention, Comparator, and Outcome (PICO) question VII was separated into two questions addressing mortality (VIIa) and clinical cure (VIIb). Methods used for study identification, screening, and evidence grading were consistent with the original guideline, with the addition of Bayesian meta-analyses. A total of 28 RCTs evaluating mortality in severely ill adults were analyzed, with pooled estimates favoring prolonged infusion (RR 0.91; 95% confidence interval 0.85 to 0.97), supported by Bayesian analyses demonstrating a 98.76% posterior probability of benefit. Across 21 RCTs evaluating clinical cure, prolonged infusion improved outcomes compared with short infusion (RR 1.11; 95% confidence interval 1.06 to 1.17), supported by Bayesian analyses demonstrating a 99.97% posterior probability of benefit. Certainty of evidence was strengthened to moderate for mortality and low for clinical cure. Consistent with the original recommendation (PICO X), subgroup analyses evaluating loading doses suggested improved outcomes when a loading dose is used before continuous infusion. Overall, the cumulative evidence reinforces and strengthens the recommendation for use of prolonged-infusion beta-lactam therapy in severely ill adult patients to improve survival and clinical cure. Continued use of loading doses when initiating continuous-infusion therapy is suggested. Future research should identify subpopulations most likely to benefit, clarify optimal prolonged-infusion strategies, and define the role of therapeutic drug monitoring. - Source: PubMed
Hong Lisa TFakhriRavari AlirezaUlldemolins MartaRoberts Jason ABonomo Robert AScheetz Marc H - Human milk banks (HMBs) are an essential clinical service, providing safe, screened donor human milk (DHM) to clinically vulnerable infants, which can enable mothers to establish their own milk supply. While HMB processes share similarities with other medical products of human origin (e.g., blood, platelets), HMBs remain marginalised services with limited resilience to external or internal pressures. As demand for DHM increases, understanding how to mitigate these vulnerabilities is essential. In November 2022, a workshop organised by the Human Milk Foundation brought together UK milk bank leaders, academics, and planners. The workshop aimed to understand existing pressures faced by UK HMBs and create a network to support strategic, evidence-based responses. Emergent themes highlighted that HMBs are stretched, facilitated largely by goodwill. Most services are reliant on limited workforces with limitations in service continuity, training, and succession planning. COVID-19 exacerbated pressures, but led to HMBs cooperating more. Proposed responses included investment in staffing, training and IT resources, greater public awareness and inter-HMB cooperation, and a national HMB Risk Register. Service continuity needs to be urgently addressed through external multiagency engagement, operational support, and research prioritization (including qualitative, technological and implementation science), defining optimal service design and financial resourcing to meet nationally agreed needs. Without intervention, the UK milk bank network may be unable to respond to future significant pressures, including specialist infant feed or infant formula shortages. With appropriate investment, a comprehensive National Service can be created to provide equitable services underpinned by robust research and innovation. - Source: PubMed
Publication date: 2026/08/12
Shenker NatalieHatia AminaGriffin SamanthaChandler-Maini GemmaBailie LizBarnett DebbieSavage EmmaD'Souza AliceDowling CarmelGane TaniaStroud SusanWood AmandaHolder GemmaCrawley HelenSibson VickyGray HelenFallon NaomiBrackley MelissaHinds HelenTurner HelenHogan MattKemp DebbieKennedy AileenKerac MarkoMeeajan RehanaMistry HemaO'Sullivan LizPatton ClareStaff MartaZuber LauraThomson MerranShariff AsmaaPsaila VikkiGreen AmandaWatt JoPartridge GemmaCrombie TinaWebster FlicCameron SimonCheema SimranBrown AmyWeaver GillianEasthope Lucy